Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Anti-TNF-? Monoclonal Antibody market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Anti-TNF-? Monoclonal Antibodymarket, defines the market attractiveness level of Anti-TNF-? Monoclonal Antibody market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Anti-TNF-? Monoclonal Antibody industry, describes the types of Anti-TNF-? Monoclonal Antibody market, the applications of major players and the market size, and deeply analyzes the current situation of the global Anti-TNF-? Monoclonal Antibody market and the development prospects and opportunities of Anti-TNF-? Monoclonal Antibody industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Anti-TNF-? Monoclonal Antibody market in Chapter 13.
By Player:
Abbive
Johnson and Johnson
UCB
By Type:
Adalimumab
Golimumab
Infliximab
Pecerizumab
By End-User:
Rheumatoid Arthritis
Ankylosing Spondylitis
Psoriasis
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Anti-TNF-? Monoclonal Antibody Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Anti-TNF-? Monoclonal Antibody Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Anti-TNF-? Monoclonal Antibody Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Anti-TNF-? Monoclonal Antibody Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Anti-TNF-? Monoclonal Antibody Market Analysis and Outlook to 2022
-
7.1 Global Anti-TNF-? Monoclonal Antibody Consumption (2017-2022)
-
7.2 United States Anti-TNF-? Monoclonal Antibody Consumption (2017-2022)
-
7.3 Europe Anti-TNF-? Monoclonal Antibody Consumption (2017-2022)
-
7.4 China Anti-TNF-? Monoclonal Antibody Consumption (2017-2022)
-
7.5 Japan Anti-TNF-? Monoclonal Antibody Consumption (2017-2022)
-
7.6 India Anti-TNF-? Monoclonal Antibody Consumption (2017-2022)
-
7.7 South Korea Anti-TNF-? Monoclonal Antibody Consumption (2017-2022)
8 Region and Country-wise Anti-TNF-? Monoclonal Antibody Market Analysis and Outlook to 2028
-
8.1 Global Anti-TNF-? Monoclonal Antibody Consumption Forecast (2022-2028)
-
8.2 United States Anti-TNF-? Monoclonal Antibody Consumption Forecast (2022-2028)
-
8.3 Europe Anti-TNF-? Monoclonal Antibody Consumption Forecast (2022-2028)
-
8.4 China Anti-TNF-? Monoclonal Antibody Consumption Forecast (2022-2028)
-
8.5 Japan Anti-TNF-? Monoclonal Antibody Consumption Forecast (2022-2028)
-
8.6 India Anti-TNF-? Monoclonal Antibody Consumption Forecast (2022-2028)
-
8.7 South Korea Anti-TNF-? Monoclonal Antibody Consumption Forecast (2022-2028)
9 Global Anti-TNF-? Monoclonal Antibody Market Outlook by Types and Applications to 2022
-
9.1 Global Anti-TNF-? Monoclonal Antibody Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Adalimumab Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Golimumab Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Infliximab Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Pecerizumab Consumption and Growth Rate (2017-2022)
-
9.2 Global Anti-TNF-? Monoclonal Antibody Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Rheumatoid Arthritis Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Ankylosing Spondylitis Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Psoriasis Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Anti-TNF-? Monoclonal Antibody Market Outlook by Types and Applications to 2028
-
10.1 Global Anti-TNF-? Monoclonal Antibody Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Adalimumab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Golimumab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Infliximab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Pecerizumab Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Anti-TNF-? Monoclonal Antibody Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Rheumatoid Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Ankylosing Spondylitis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Psoriasis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Anti-TNF-? Monoclonal Antibody Import and Export Analysis (Top 5 Countries)
-
11.1 Global Anti-TNF-? Monoclonal Antibody Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Anti-TNF-? Monoclonal Antibody Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Anti-TNF-? Monoclonal Antibody Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Anti-TNF-? Monoclonal Antibody Market Competitive Analysis
-
14.1 Abbive
-
14.1.1 Abbive Company Details
-
14.1.2 Abbive Anti-TNF-? Monoclonal Antibody Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Abbive Anti-TNF-? Monoclonal Antibody Product and Service
-
14.2 Johnson and Johnson
-
14.2.1 Johnson and Johnson Company Details
-
14.2.2 Johnson and Johnson Anti-TNF-? Monoclonal Antibody Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Johnson and Johnson Anti-TNF-? Monoclonal Antibody Product and Service
-
14.3 UCB
-
14.3.1 UCB Company Details
-
14.3.2 UCB Anti-TNF-? Monoclonal Antibody Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 UCB Anti-TNF-? Monoclonal Antibody Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Anti-TNF-? Monoclonal Antibody
-
Figure Anti-TNF-? Monoclonal Antibody Picture
-
Table Global Anti-TNF-? Monoclonal Antibody Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-TNF-? Monoclonal Antibody Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-TNF-? Monoclonal Antibody Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Anti-TNF-? Monoclonal Antibody Consumption by Country (2017-2022)
-
Figure United States Anti-TNF-? Monoclonal Antibody Consumption and Growth Rate (2017-2022)
-
Table Europe Anti-TNF-? Monoclonal Antibody Consumption and Growth Rate (2017-2022)
-
Figure China Anti-TNF-? Monoclonal Antibody Consumption and Growth Rate (2017-2022)
-
Figure Japan Anti-TNF-? Monoclonal Antibody Consumption and Growth Rate (2017-2022)
-
Figure India Anti-TNF-? Monoclonal Antibody Consumption and Growth Rate (2017-2022)
-
Figure South Korea Anti-TNF-? Monoclonal Antibody Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-TNF-? Monoclonal Antibody Consumption Forecast by Country (2022-2028)
-
Figure United States Anti-TNF-? Monoclonal Antibody Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Anti-TNF-? Monoclonal Antibody Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Anti-TNF-? Monoclonal Antibody Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Anti-TNF-? Monoclonal Antibody Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Anti-TNF-? Monoclonal Antibody Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Anti-TNF-? Monoclonal Antibody Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adalimumab Consumption and Growth Rate (2017-2022)
-
Figure Global Golimumab Consumption and Growth Rate (2017-2022)
-
Figure Global Infliximab Consumption and Growth Rate (2017-2022)
-
Figure Global Pecerizumab Consumption and Growth Rate (2017-2022)
-
Figure Global Rheumatoid Arthritis Consumption and Growth Rate (2017-2022)
-
Figure Global Ankylosing Spondylitis Consumption and Growth Rate (2017-2022)
-
Figure Global Psoriasis Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Adalimumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Golimumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Infliximab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pecerizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rheumatoid Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ankylosing Spondylitis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Psoriasis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Anti-TNF-? Monoclonal Antibody Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Anti-TNF-? Monoclonal Antibody Export by Region (Top 5 Countries) (2017-2028)
-
Table Abbive (Foundation Year, Company Profile and etc.)
-
Table Abbive Anti-TNF-? Monoclonal Antibody Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbive Anti-TNF-? Monoclonal Antibody Product and Service
-
Table Johnson and Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson and Johnson Anti-TNF-? Monoclonal Antibody Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson and Johnson Anti-TNF-? Monoclonal Antibody Product and Service
-
Table UCB (Foundation Year, Company Profile and etc.)
-
Table UCB Anti-TNF-? Monoclonal Antibody Sales, Price, Value and Gross Profit (2017-2022)
-
Table UCB Anti-TNF-? Monoclonal Antibody Product and Service
-
